PleoPharma Showcases Promising Results in Study on Cannabis Withdrawal Syndrome
PHOENIXVILLE, PA – PleoPharma, Inc. recently presented new data from its Phase 1b study on Cannabis Withdrawal Syndrome (CWS) at the American Academy of Addiction Psychiatry’s annual meeting in Naples, …
PleoPharma Showcases Promising Results in Study on Cannabis Withdrawal Syndrome Read More